Momenta Pharma (MNTA) Stock Price & Overview

NASDAQ:MNTA

Current stock price

52.48
-0.01 (-0.02%)
At close:
52.49
+0.01 (+0.02%)
After Hours:

The current stock price of MNTA is 52.48 null. Today MNTA is down by -0.02%. In the past month the price increased by 0.63%. In the past year, price increased by 300.15%.

MNTA Key Statistics

52-Week Range12.58 - 52.53
Current MNTA stock price positioned within its 52-week range.
1-Month Range52.02 - 52.53
Current MNTA stock price positioned within its 1-month range.
Market Cap
6.247B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.23
Dividend Yield
N/A

MNTA Stock Performance

Today
-0.02%
1 Week
+0.36%
1 Month
+0.63%
3 Months
+62.63%
Longer-term
6 Months +116.95%
1 Year +300.15%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

MNTA Stock Chart

Momenta Pharma / MNTA Daily stock chart

MNTA Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to MNTA. When comparing the yearly performance of all stocks, MNTA is one of the better performing stocks in the market, outperforming 98.46% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
MNTA Full Technical Analysis Report

MNTA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to MNTA. MNTA has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
MNTA Full Fundamental Analysis Report

MNTA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
MNTA Earnings History

MNTA Forecast & Estimates


Analysts
Analysts68.8
Price TargetN/A
EPS Next Y42.9%
Revenue Next YearN/A
MNTA Forecast & Estimates

MNTA Financial Highlights

Over the last trailing twelve months MNTA reported a non-GAAP Earnings per Share(EPS) of -2.23. The EPS decreased by -4.21% compared to the year before.


Income Statements
Revenue(TTM)30.07M
Net Income(TTM)-227.83M
Industry RankSector Rank
PM (TTM) -757.62%
ROA -43.54%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%58.62%
Sales Q2Q%27.56%
EPS 1Y (TTM)-4.21%
Revenue 1Y (TTM)-55.12%
MNTA financials

MNTA Ownership

Ownership
Inst Owners0.04%
Shares119.03M
Float71.38M
Ins Owners1.21%
Short Float %N/A
Short RatioN/A
MNTA Ownership

About MNTA

Company Profile

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and its manufacturing process. They are applying their innovative technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

Company Info

Momenta Pharma

301 BINNEY STREET

CAMBRIDGE MA 02142

CEO: Craig A. Wheeler

Phone: 617-491-9700

Momenta Pharma / MNTA FAQ

What does MNTA do?

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and its manufacturing process. They are applying their innovative technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.


Can you provide the latest stock price for Momenta Pharma?

The current stock price of MNTA is 52.48 null. The price decreased by -0.02% in the last trading session.


Does MNTA stock pay dividends?

MNTA does not pay a dividend.


How is the ChartMill rating for Momenta Pharma?

MNTA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Who owns Momenta Pharma?

You can find the ownership structure of Momenta Pharma (MNTA) on the Ownership tab.